Market research
ABG.F AmerisourceBergen Corporation
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 53B
- P/E ratio
- 23.92
- Analyst target
- 140.85
- Dividend yield
- 0.8%
- Beta
- 0.57
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Distribution
- ISIN
- US03073E1055
- Market cap
- 53B
- P/E ratio
- 23.92
- Analyst target
- 140.85
- Dividend yield
- 0.8%
- Beta
- 0.57
About
About AmerisourceBergen Corporation
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ABG.F discussion.
5 years, 5 months ago
AmerisourceBergen Corporation is currently in a long term uptrend where the price is trading 6.2% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
AmerisourceBergen Corporation's total revenue rose by 9.7% to $53B since the same quarter in the previous year.
Its net income has increased by 99.8% to $375M since the same quarter in the previous year.
Finally, its free cash flow grew by 1009.4% to $838M since the same quarter in the previous year.
Based on the above factors, AmerisourceBergen Corporation gets an overall score of 5/5.